Leucovorin (folinic acid) rescue for high‐dose methotrexate: A review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Leucovorin (folinic acid) rescue for high‐dose methotrexate: A review

Published:2022-08-05 Issue:9 Volume:47 Page:1452-1460
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:Clinical Pharmacy Therapeu

Author:

Jiang Ruiqi¹²,Mei Shenghui¹²^ORCID,Zhao Zhigang¹²

Affiliation:

1. Department of Pharmacy, Beijing Tiantan Hospital Capital Medical University Beijing People's Republic of China

2. Department of Clinical Pharmacology, College of Pharmaceutical Sciences Capital Medical University Beijing People's Republic of China

Funder

National Key Research and Development Program of China

Publisher

Hindawi Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13739

Reference53 articles.

1. Preventing and Managing Toxicities of High-Dose Methotrexate

2. Concepts in use of high-dose methotrexate therapy

3. The Pharmacology and Clinical Use of Methotrexate

4. Implementation and evaluation of high-dose methotrexate administration guidelines

5. Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating methotrexate toxicity: Examining the therapeutic roles of folinic acid and glucarpidase;British Journal of Clinical Pharmacology;2024-06-18

2. Cancer drugs and acute kidney injury: new therapies and new challenges;Current Opinion in Nephrology & Hypertension;2024-05-07

3. Is it possible to predict the success of single dose methotrexate in the treatment of tubal ectopic pregnancies?;Ginekologia Polska;2023-03-31

4. Research Progress in Folic Acid Supplementation Treatment in Patients with Inflammatory Bowel Disease;Advances in Clinical Medicine;2023

5. Target concentration achievement for efficacy and safety of patients with osteosarcoma treated with high‑dose methotrexate based on individual pharmacokinetics: A retrospective study;Oncology Letters;2022-12-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3